Literature DB >> 31720711

Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.

K Lee1, S Lim1, H Park1, H Y Woo1, Y Chang2, E Sung2, H S Jung2, K E Yun2, C W Kim2, S Ryu2, M J Kwon3,4.   

Abstract

Thyroid dysfunction is associated with the loss of bone density (osteoporosis). However, the connection between subclinical thyroid dysfunction and osteoporosis remains controversial. This study found no apparent association between subclinical hypothyroidism or subclinical hyperthyroidism and bone mineral density (BMD) in the lumbar spine and femur.
INTRODUCTION: The present study examined the relationship between subclinical thyroid dysfunction and BMD in healthy middle-aged adults.
METHODS: A total of 25,510 healthy Koreans with normal free thyroxine levels were enrolled from January 2011 to December 2016, and 91% of subjects visited only once. The average age of the 15,761 women was 45, and the average age of the 9749 men was 48. Levels of thyroid-stimulating hormone (TSH) and BMD were recorded in all subjects. BMD was measured using dual-energy X-ray absorptiometry.
RESULTS: No apparent association was found between subclinical thyroid dysfunction and BMD in the lumbar spine, femur-neck, and proximal femur sites compared with a euthyroid group. Age, body mass index (BMI), and postmenopausal status affected BMD in women, and only BMI affected BMD in men. Subclinical hypothyroidism was independently associated with a lower risk of osteoporosis (odds ratio 0.657, 95% confidence interval 0.464-0.930) in 4710 postmenopausal women.
CONCLUSIONS: No apparent association was found between subclinical hypothyroidism or subclinical hyperthyroidism defined on single TSH measurement and BMD at the lumbar spine and femur in a large cohort of middle-aged men and women. Subclinical hypothyroidism was independently associated with a lower risk of osteoporosis in postmenopausal women.

Entities:  

Keywords:  Bone mineral density; Osteoporosis; Subclinical thyroid dysfunction

Mesh:

Year:  2019        PMID: 31720711     DOI: 10.1007/s00198-019-05205-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  35 in total

1.  Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women.

Authors:  Won Young Lee; Ki Won Oh; Eun Jung Rhee; Chan Hee Jung; Sun Woo Kim; Eun Joo Yun; Hyun Jung Tae; Ki Hyun Baek; Moo Il Kang; Moon Gi Choi; Hyung Joon Yoo; Sung Woo Park
Journal:  Arch Med Res       Date:  2006-05       Impact factor: 2.235

Review 2.  Subclinical thyroid disease.

Authors:  George R Wilson; R Whit Curry
Journal:  Am Fam Physician       Date:  2005-10-15       Impact factor: 3.292

3.  The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis.

Authors:  Bo Abrahamsen; Henrik L Jørgensen; Anne Sofie Laulund; Mads Nybo; Doug C Bauer; Thomas H Brix; Laszlo Hegedüs
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

4.  Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women.

Authors:  Duk Jae Kim; Young Ho Khang; Jung-Min Koh; Young Kee Shong; Ghi Su Kim
Journal:  Clin Endocrinol (Oxf)       Date:  2006-01       Impact factor: 3.478

5.  Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women.

Authors:  Elaine Murphy; Claus C Glüer; David M Reid; Dieter Felsenberg; Christian Roux; Richard Eastell; Graham R Williams
Journal:  J Clin Endocrinol Metab       Date:  2010-04-21       Impact factor: 5.958

6.  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.

Authors:  Ane Garmendia Madariaga; Silvia Santos Palacios; Francisco Guillén-Grima; Juan C Galofré
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

7.  Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway.

Authors:  Anders Svare; Tom Ivar Lund Nilsen; Bjørn Olav Asvold; Siri Forsmo; Berit Schei; Trine Bjøro; Arnulf Langhammer
Journal:  Eur J Endocrinol       Date:  2013-10-23       Impact factor: 6.664

8.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.

Authors:  Jeffrey R Garber; Rhoda H Cobin; Hossein Gharib; James V Hennessey; Irwin Klein; Jeffrey I Mechanick; Rachel Pessah-Pollack; Peter A Singer; Kenneth A Woeber
Journal:  Thyroid       Date:  2012-11-06       Impact factor: 6.568

9.  Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015.

Authors:  Won Gu Kim; Won Bae Kim; Gyeongji Woo; Hyejin Kim; Yumi Cho; Tae Yong Kim; Sun Wook Kim; Myung Hee Shin; Jin Woo Park; Hai Lin Park; Kyungwon Oh; Jae Hoon Chung
Journal:  Endocrinol Metab (Seoul)       Date:  2017-01-23

10.  Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015).

Authors:  So Young Park; Hae In Kim; Hyun-Kyung Oh; Tae Hyuk Kim; Hye Won Jang; Jae Hoon Chung; Myung-Hee Shin; Sun Wook Kim
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more
  3 in total

Review 1.  Endocrine Regulation on Bone by Thyroid.

Authors:  Siyuan Zhu; Yidan Pang; Jun Xu; Xiaoyi Chen; Changqing Zhang; Bo Wu; Junjie Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-05       Impact factor: 6.055

Review 2.  Thyrotropin, Hyperthyroidism, and Bone Mass.

Authors:  Se-Min Kim; Vitaly Ryu; Sari Miyashita; Funda Korkmaz; Daria Lizneva; Sakshi Gera; Rauf Latif; Terry F Davies; Jameel Iqbal; Tony Yuen; Mone Zaidi
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

Review 3.  Thyroid Hormone Diseases and Osteoporosis.

Authors:  Alessandro P Delitala; Angelo Scuteri; Carlo Doria
Journal:  J Clin Med       Date:  2020-04-06       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.